PRALNACASAN
UNII N986NI319S

Substance Identification & Data

This profile provides standardized clinical and technical data for Pralnacasan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N986NI319S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 192755-52-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N986NI319S

CAS Registry Number

192755-52-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRALNACASAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H29N5O7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CXAGHAZMQSCAKJ-WAHHBDPQSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C76768

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

153270

Unique identification number in the NCBI database of chemical substances.

INN ID

8149

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MM-50

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1C[C@@H](C(N2[C@@H](CCCN2C1=O)C(N[C@@H]3[C@@H](OC(C3)=O)OCC)=O)=O)NC(=O)c4c5c(ccn4)cccc5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pralnacasan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.